Marine Auffret

904 total citations
47 papers, 531 citations indexed

About

Marine Auffret is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Marine Auffret has authored 47 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Toxicology, 10 papers in Pediatrics, Perinatology and Child Health and 9 papers in Epidemiology. Recurrent topics in Marine Auffret's work include Pharmacovigilance and Adverse Drug Reactions (11 papers), Pharmaceutical studies and practices (7 papers) and Drug-Induced Adverse Reactions (5 papers). Marine Auffret is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (11 papers), Pharmaceutical studies and practices (7 papers) and Drug-Induced Adverse Reactions (5 papers). Marine Auffret collaborates with scholars based in France, United States and Canada. Marine Auffret's co-authors include Sophie Gautier, Johana Béné, Pierrick Coupé, Benjamin Rolland, Dominique Hillaire‐Buys, Samy Babai, Guillaume Moulis, Sylvie Deheul, Régis Bordet and Olivier Cottencin and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and British Journal of Dermatology.

In The Last Decade

Marine Auffret

44 papers receiving 524 citations

Peers

Marine Auffret
Getaw Worku Hassen United States
Elizabeth A. Bundock United States
Elisabeth Hazard United States
Markay Hopps United States
H. Irving Pierce United States
Ahmed Kotb Canada
Marine Auffret
Citations per year, relative to Marine Auffret Marine Auffret (= 1×) peers Waldir Antônio Tognola

Countries citing papers authored by Marine Auffret

Since Specialization
Citations

This map shows the geographic impact of Marine Auffret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marine Auffret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marine Auffret more than expected).

Fields of papers citing papers by Marine Auffret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marine Auffret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marine Auffret. The network helps show where Marine Auffret may publish in the future.

Co-authorship network of co-authors of Marine Auffret

This figure shows the co-authorship network connecting the top 25 collaborators of Marine Auffret. A scholar is included among the top collaborators of Marine Auffret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marine Auffret. Marine Auffret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Auffret, Marine, et al.. (2025). Safety of ifosfamide during pregnancy: A comprehensive analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 311. 114003–114003. 1 indexed citations
2.
Nourredine, Mikaïl, Luc Zimmer, Benjamin Rolland, et al.. (2024). NMDA antagonist agents for the treatment of symptoms in autism spectrum disorder: a systematic review and meta-analysis. Frontiers in Pharmacology. 15. 1395867–1395867. 3 indexed citations
3.
Delinière, Antoine, et al.. (2023). Green tea and nadolol interaction: A risk of therapeutic inefficiency, a case report and extensive review. Therapies. 79(4). 482–485. 2 indexed citations
4.
Auffret, Marine, et al.. (2022). Guillain–Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data. Clinical Drug Investigation. 42(7). 581–592. 14 indexed citations
5.
Tod, Michel, et al.. (2022). Quantitative Prediction of Adverse Event Probability Due to Pharmacokinetic Interactions. Drug Safety. 45(7). 755–764. 2 indexed citations
6.
Grenet, Guillaume, Sabine Mainbourg, Marine Auffret, et al.. (2021). DPP-4 Inhibitors and Respiratory Infection: A Systematic Review and Meta-analysis of the Cardiovascular Outcomes Trials. Diabetes Care. 44(3). e36–e37. 9 indexed citations
7.
Nourredine, Mikaïl, Lucie Jurek, Marine Auffret, et al.. (2020). Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis. CNS Spectrums. 26(5). 459–467. 22 indexed citations
8.
Auffret, Marine, Benjamin Rolland, Hélène Behal, et al.. (2019). A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in France. Therapies. 74(6). 645–650. 1 indexed citations
9.
Veyrac, G., et al.. (2017). Pristinamycin-induced arthralgia and myalgia: Analysis of the French Pharmacovigilance Database. Médecine et Maladies Infectieuses. 48(1). 58–62. 2 indexed citations
10.
Auffret, Marine, et al.. (2016). Misoprostol exposure during the first trimester of pregnancy: Is the malformation risk varying depending on the indication?. European Journal of Obstetrics & Gynecology and Reproductive Biology. 207. 188–192. 11 indexed citations
11.
Béné, Johana, et al.. (2016). Évaluation du site internet du centre régional de pharmacovigilance du Nord-Pas-de-Calais. Therapies. 71(3). 329–333. 1 indexed citations
12.
Rolland, Benjamin, Julien Labreuche, Alain Duhamel, et al.. (2015). Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation. European Neuropsychopharmacology. 25(10). 1631–1636. 43 indexed citations
13.
Auffret, Marine, Benjamin Rolland, Sylvie Deheul, et al.. (2015). Attitudes of community pharmacists to off-label prescribing of baclofen in Northern France. International Journal of Clinical Pharmacy. 37(2). 296–299. 3 indexed citations
14.
Rolland, Benjamin, Carole Langlois, Marine Auffret, et al.. (2014). Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen. International Clinical Psychopharmacology. 30(1). 49–53. 21 indexed citations
15.
Béné, Johana, Guillaume Moulis, Marine Auffret, et al.. (2014). Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database. Lara D. Veeken. 53(8). 1465–1469. 25 indexed citations
16.
Geoffroy, Pierre A., Marine Auffret, Sylvie Deheul, et al.. (2014). Baclofen-Induced Manic Symptoms: Case Report and Systematic Review. Psychosomatics. 55(4). 326–332. 27 indexed citations
17.
Ajana, Faïza, A. Pasquet, Marine Auffret, & Sophie Gautier. (2013). Fluctuating Anaemia in Treated HIV Patients: Could be a PICA?. Therapies. 68(1). 49–51. 1 indexed citations
18.
Auffret, Marine, et al.. (2012). Entérocolite neutropénique associée au docétaxel, un effet indésirable rare mais redoutable : à propos d’un cas. Journal de Pharmacie Clinique. 31(3). 163–166.
19.
Auffret, Marine, et al.. (1972). Effet de l'ingestion du p-diméthylaminoazobenzène (DAB) et du 3' méthyl-DAB sur les capacités d'activation du DAB et d'azoréduction des microsomes de foie de rat.. Comptes rendus hebdomadaires des séances de l Académie des sciences. 274(5). 1 indexed citations
20.
Auffret, Marine, et al.. (1968). [Zieve's syndrome, alcoholic hyperlipemia and hemolytic anemia].. PubMed. 76(8). 371–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026